Compare Abeona Therapeutics Inc (ABEO) vs Fiverr International Ltd (FVRR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Fiverr International Ltd — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while Fiverr International Ltd trades at $10.85 (market cap $403.37M). The key difference: Abeona Therapeutics Inc and Fiverr International Ltd are close in size by market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Fiverr International Ltd nearer its low. Which is the better fit depends on your goals.
| ABEO | FVRR | |
|---|---|---|
Market Cap | $373.32M | $403.37M |
Sector | Health | Industrials |
52-Week High | $7.23 | $27.77 |
52-Week Low | $4.17 | $9.62 |
Enterprise Value | $228.22M | $133.97M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Fiverr International (FVRR) trades at $11.22, up 3.79% today, showing signs of recovery from recent lows. The stock appears fundamentally undervalued with a P/E of 14.44 and P/S of 0.96, while revenue growth has been steady from $337M in 2022 to $431M in 2025. Recent earnings show mixed results with Q1 2026 missing expectations, but technical indicators suggest bullish momentum with strong moving average support.
FVRR presents a contrarian opportunity with attractive valuation metrics and improving profitability, though investor sentiment remains cautious due to active buyer declines and ongoing legal investigations. The company's strategy shift and strong gross margins of 81.86% provide upside potential, but competitive pressures and execution risks require careful monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →
